Home/Filings/4/0000950170-25-085074
4//SEC Filing

BURNETT JOSEPH 4

Accession 0000950170-25-085074

CIK 0001285550other

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 9:50 PM ET

Size

6.5 KB

Accession

0000950170-25-085074

Insider Transaction Report

Form 4
Period: 2025-06-09
BURNETT JOSEPH
DirectorCEO and President
Transactions
  • Sale

    Common Stock

    2025-06-09$13.29/sh21,247$282,373243,522 total(indirect: See Footnote)
Holdings
  • Common Stock

    25,363
Footnotes (3)
  • [F1]This sale of shares is incident to the net share settlement of 21,247 shares which vested on March 6, 2025 under a restricted stock unit granted to the reporting person on March 6, 2023.
  • [F2]Represents a weighted average sales price per share. The shares were sold at prices ranging from $13.20 to $13.51. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  • [F3]These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.

Documents

1 file

Issuer

ClearPoint Neuro, Inc.

CIK 0001285550

Entity typeother

Related Parties

1
  • filerCIK 0001721010

Filing Metadata

Form type
4
Filed
Jun 10, 8:00 PM ET
Accepted
Jun 11, 9:50 PM ET
Size
6.5 KB